180 related articles for article (PubMed ID: 30513960)
1. Combined Gastric and Colorectal Cancer Screening-A New Strategy.
Selgrad M; Bornschein J; Kandulski A; Weigt J; Roessner A; Wex T; Malfertheiner P
Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30513960
[TBL] [Abstract][Full Text] [Related]
2. The correlation between histological gastritis staging- 'OLGA/OLGIM' and serum pepsinogen test in assessment of gastric atrophy/intestinal metaplasia in China.
Wang X; Lu B; Meng L; Fan Y; Zhang S; Li M
Scand J Gastroenterol; 2017 Aug; 52(8):822-827. PubMed ID: 28436254
[TBL] [Abstract][Full Text] [Related]
3. The application of new gastric cancer screening score system for gastric cancer screening and risk assessment of gastric precancerous lesions in China.
Wang X; Zhang Q; Han F; Wu Y
Scand J Gastroenterol; 2023 Jan; 58(1):34-37. PubMed ID: 35868004
[No Abstract] [Full Text] [Related]
4. Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer.
Zhou Y; Li HY; Zhang JJ; Chen XY; Ge ZZ; Li XB
World J Gastroenterol; 2016 Apr; 22(13):3670-8. PubMed ID: 27053859
[TBL] [Abstract][Full Text] [Related]
5. OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population.
Nam JH; Choi IJ; Kook MC; Lee JY; Cho SJ; Nam SY; Kim CG
Helicobacter; 2014 Apr; 19(2):81-9. PubMed ID: 24617667
[TBL] [Abstract][Full Text] [Related]
6. Comparison of operative link for gastritis assessment, operative link on gastric intestinal metaplasia assessment, and TAIM stagings among men with atrophic gastritis.
Nieminen AA; Kontto J; Puolakkainen P; Virtamo J; Kokkola A
World J Gastroenterol; 2020 Jun; 26(24):3447-3457. PubMed ID: 32655268
[TBL] [Abstract][Full Text] [Related]
7. HELICOBACTER PYLORI CHRONIC GASTRITIS ON PATIENTS WITH PREMALIGNANT CONDITIONS: OLGA AND OLGIM EVALUATION AND SERUM BIOMARKERS PERFORMANCE.
Coelho MCF; Ribeiro HG; Gomes CGO; Marinho FP; Barbosa AJA; Coelho LGV
Arq Gastroenterol; 2021; 58(1):39-47. PubMed ID: 33909795
[TBL] [Abstract][Full Text] [Related]
8. ROLE OF INCISURA ANGULARIS BIOPSY IN GASTRITIS STAGING AND RISK ASSESSMENT OF GASTRIC CÂNCER.
Ferrari F; Ogata DC; Mello CAL
Arq Gastroenterol; 2023; 60(4):478-489. PubMed ID: 38018553
[TBL] [Abstract][Full Text] [Related]
9. Serum pepsinogen levels and OLGA/OLGIM staging in the assessment of atrophic gastritis types.
Ogutmen Koc D; Bektas S
Postgrad Med J; 2022 Jun; 98(1160):441-445. PubMed ID: 33380437
[TBL] [Abstract][Full Text] [Related]
10. Impact of the angulus biopsy for the detection of gastric preneoplastic conditions and gastric cancer risk assessment.
Varbanova M; Wex T; Jechorek D; Röhl FW; Langner C; Selgrad M; Malfertheiner P
J Clin Pathol; 2016 Jan; 69(1):19-25. PubMed ID: 26163538
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment of metachronous gastric cancer development using OLGA and OLGIM systems after endoscopic submucosal dissection for early gastric cancer: a long-term follow-up study.
Na YS; Kim SG; Cho SJ
Gastric Cancer; 2023 Mar; 26(2):298-306. PubMed ID: 36609936
[TBL] [Abstract][Full Text] [Related]
12. [Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems].
Ben Slama S; Ben Ghachem D; Dhaoui A; Jomni MT; Dougui MH; Bellil K
Pan Afr Med J; 2016; 23():28. PubMed ID: 27200133
[TBL] [Abstract][Full Text] [Related]
13. High-risk individuals for gastric cancer would be missed for surveillance without subtyping of intestinal metaplasia.
Isajevs S; Savcenko S; Liepniece-Karele I; Piazuelo MB; Kikuste I; Tolmanis I; Vanags A; Gulbe I; Mezmale L; Samentaev D; Tazedinov A; Samsutdinov R; Belihina T; Igissinov N; Leja M
Virchows Arch; 2021 Oct; 479(4):679-686. PubMed ID: 33990867
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of OLGA and OLGIM system not only for intestinal type but also for diffuse type of gastric cancer, and no interaction among the gastric cancer risk factors.
Yun CY; Kim N; Lee J; Lee JY; Hwang YJ; Lee HS; Yoon H; Shin CM; Park YS; Kim JW; Lee DH
Helicobacter; 2018 Dec; 23(6):e12542. PubMed ID: 30303591
[TBL] [Abstract][Full Text] [Related]
15. The corpus-predominant gastritis index can be an early and reversible marker to identify the gastric cancer risk of Helicobacter pylori-infected nonulcer dyspepsia.
Cheng HC; Tsai YC; Yang HB; Yeh YC; Chang WL; Kuo HY; Lu CC; Sheu BS
Helicobacter; 2017 Aug; 22(4):. PubMed ID: 28326664
[TBL] [Abstract][Full Text] [Related]
16. Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment.
Rugge M; Fassan M; Pizzi M; Farinati F; Sturniolo GC; Plebani M; Graham DY
World J Gastroenterol; 2011 Nov; 17(41):4596-601. PubMed ID: 22147965
[TBL] [Abstract][Full Text] [Related]
17. The OLGA-OLGIM staging and the interobserver agreement for gastritis and preneoplastic lesion screening: a cross-sectional study.
Salazar BE; Pérez-Cala T; Gomez-Villegas SI; Cardona-Zapata L; Pazos-Bastidas S; Cardona-Estepa A; Vélez-Gómez DE; Justinico-Castro JA; Bernal-Cobo A; Dávila-Giraldo HA; Benítez-Guerra JC; Valencia-Cárdenas JT; Ospina EJ; Castaño-Llano R; Bravo MM; Cataño-Correa JC; Zabaleta J; Trespalacios-Rangel AA; Cock-Botero AM; Roldán-Pérez MI; Martínez A
Virchows Arch; 2022 Apr; 480(4):759-769. PubMed ID: 35089403
[TBL] [Abstract][Full Text] [Related]
18. [ANALYSIS OF THE RESULTS OF ENDOSCOPIC AND MORPHOLOGICAL STUDIES OF THE STOMACH MUCOSA WITH REDUCED PEPSINOGEN-I IN PATIENTS WITH H. PYLORI (H.P.)--ASSOCIATED GASTRITIS IN TOMSK AND TOMSK REGION].
Beloborodova EV; Purlik IL; Li NA; Rachkovskiy MI; Sanzharovskaya MS
Eksp Klin Gastroenterol; 2015; (4):66-70. PubMed ID: 26415268
[TBL] [Abstract][Full Text] [Related]
19. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
[TBL] [Abstract][Full Text] [Related]
20. Assessment of Gastritis and Gastric Cancer Risk in the Chilean Population Using the OLGA System.
Bellolio E; Riquelme I; Riffo-Campos AL; Rueda C; Ferreccio C; Villaseca M; Brebi P; Muñoz S; Araya JC
Pathol Oncol Res; 2019 Jul; 25(3):1135-1142. PubMed ID: 30467699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
